"Without their support and guidance, BioRexis would have never even gotten off the ground. It was in every sense an honor and pleasure to be their partners in BioRexis. "
— David R. King, CEO
Pharma & Biotech
We have invested in a range of pharmaceutical companies across our funds. A major area of success has been investments into commercial stage companies seeking to establish a leading franchise position for their product(s). We have helped a number of companies in this capacity, including Adams Respiratory (developers of Mucinex), BioRexis, Synageva BioPharma, and others.
INVESTMENT CASE STUDY: Pharma & Biotech Investment
BioRexis — Developer of novel, long-lasting versions of known biopharmaceuticals using proprietary protein engineering technology. Products can also be produced in highly efficient, yeast-based manufacturing systems.